FI875159A0 - Method for the preparation of therapeutically useful, (3S (Z)] - 2 - [[1- (2-amino-4-thiazolyl) -2- [2,2-dimethyl-4-oxo-1- (sulfooxy) - For the preparation of crystalline dierythromycin and dicoline salts of 3-azetidinyl / amino / -2-oxoethylidene / amino / oxy / acetic acid - Google Patents

Method for the preparation of therapeutically useful, (3S (Z)] - 2 - [[1- (2-amino-4-thiazolyl) -2- [2,2-dimethyl-4-oxo-1- (sulfooxy) - For the preparation of crystalline dierythromycin and dicoline salts of 3-azetidinyl / amino / -2-oxoethylidene / amino / oxy / acetic acid

Info

Publication number
FI875159A0
FI875159A0 FI875159A FI875159A FI875159A0 FI 875159 A0 FI875159 A0 FI 875159A0 FI 875159 A FI875159 A FI 875159A FI 875159 A FI875159 A FI 875159A FI 875159 A0 FI875159 A0 FI 875159A0
Authority
FI
Finland
Prior art keywords
amino
preparation
dicoline
dierythromycin
oxoethylidene
Prior art date
Application number
FI875159A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI91757C (en
FI91757B (en
FI875159A (en
Inventor
William Lawrence Parker
Edward Morton Cohen
William Henry Koster
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI875159A0 publication Critical patent/FI875159A0/en
Publication of FI875159A publication Critical patent/FI875159A/en
Application granted granted Critical
Publication of FI91757B publication Critical patent/FI91757B/en
Publication of FI91757C publication Critical patent/FI91757C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI875159A 1986-12-19 1987-11-23 Process for the preparation of therapeutically useful, (3S (Z)] - 2 - [[1- (2-amino-4-thiazolyl) -2- [2,2-dimethyl-4-oxo-1- (sulfooxy) - For the preparation of crystalline dierythromycin and dicoline salts of 3-azetidinyl / amino / -2-oxoethylidene / amino / oxy / acetic acid FI91757C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/944,283 US4751220A (en) 1986-12-19 1986-12-19 Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US94428386 1986-12-19

Publications (4)

Publication Number Publication Date
FI875159A0 true FI875159A0 (en) 1987-11-23
FI875159A FI875159A (en) 1988-06-20
FI91757B FI91757B (en) 1994-04-29
FI91757C FI91757C (en) 1994-08-10

Family

ID=25481130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875159A FI91757C (en) 1986-12-19 1987-11-23 Process for the preparation of therapeutically useful, (3S (Z)] - 2 - [[1- (2-amino-4-thiazolyl) -2- [2,2-dimethyl-4-oxo-1- (sulfooxy) - For the preparation of crystalline dierythromycin and dicoline salts of 3-azetidinyl / amino / -2-oxoethylidene / amino / oxy / acetic acid

Country Status (25)

Country Link
US (1) US4751220A (en)
JP (1) JP2511083B2 (en)
KR (1) KR960007534B1 (en)
AU (1) AU600536B2 (en)
BE (1) BE1000625A3 (en)
CA (1) CA1296717C (en)
CH (1) CH674009A5 (en)
DE (1) DE3743111C2 (en)
DK (1) DK671487A (en)
ES (1) ES2007766A6 (en)
FI (1) FI91757C (en)
FR (1) FR2610627B1 (en)
GB (1) GB2199033B (en)
GR (1) GR871937B (en)
HU (1) HU197568B (en)
IE (1) IE61325B1 (en)
IL (1) IL84521A (en)
IT (1) IT1233457B (en)
LU (1) LU87076A1 (en)
NL (1) NL193639C (en)
NZ (1) NZ222599A (en)
PH (1) PH23170A (en)
PT (1) PT86403B (en)
SE (1) SE467782B (en)
ZA (1) ZA879031B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
EP1463807A4 (en) * 2001-12-19 2006-04-12 Bristol Myers Squibb Co Pichia pastoris formate dehydrogenase and uses therefor
CN101724000B (en) * 2008-10-29 2012-05-30 广东东阳光药业有限公司 Crystallization method of erythrocin
CN113754651B (en) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 Beta-lactam compound, application and preparation method thereof
CN115463219A (en) * 2021-11-09 2022-12-13 中国医学科学院医药生物技术研究所 Pharmaceutical composition containing beta-lactam compound and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES376380A1 (en) * 1970-01-30 1972-04-16 Roger Lab Procedure for obtaining a new derivative of erythromycin. (Machine-translation by Google Translate, not legally binding)
AU8364875A (en) * 1974-08-21 1977-02-10 Hoffmann La Roche Choline and n-methyl-d-glucamine salts of amoxycillin
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4638061A (en) * 1985-01-28 1987-01-20 E. R. Squibb & Sons, Inc. [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Also Published As

Publication number Publication date
SE8705068L (en) 1988-06-20
DK671487D0 (en) 1987-12-18
BE1000625A3 (en) 1989-02-21
SE467782B (en) 1992-09-14
LU87076A1 (en) 1988-07-14
HUT45998A (en) 1988-09-28
GB8727048D0 (en) 1987-12-23
AU600536B2 (en) 1990-08-16
CA1296717C (en) 1992-03-03
NZ222599A (en) 1989-09-27
SE8705068D0 (en) 1987-12-18
FR2610627B1 (en) 1989-12-01
KR960007534B1 (en) 1996-06-05
KR880007528A (en) 1988-08-27
PT86403B (en) 1990-11-20
DK671487A (en) 1988-06-20
IT1233457B (en) 1992-04-02
HU197568B (en) 1989-04-28
PH23170A (en) 1989-05-19
ZA879031B (en) 1988-05-27
NL8703047A (en) 1988-07-18
JP2511083B2 (en) 1996-06-26
PT86403A (en) 1988-01-01
CH674009A5 (en) 1990-04-30
IT8722908A0 (en) 1987-12-07
GR871937B (en) 1988-04-26
AU8185787A (en) 1988-06-23
US4751220A (en) 1988-06-14
IL84521A0 (en) 1988-04-29
NL193639B (en) 2000-01-03
FI91757C (en) 1994-08-10
DE3743111A1 (en) 1988-06-30
NL193639C (en) 2000-05-04
DE3743111C2 (en) 1996-04-04
FI91757B (en) 1994-04-29
ES2007766A6 (en) 1989-07-01
GB2199033B (en) 1990-10-24
IE873447L (en) 1988-06-19
FI875159A (en) 1988-06-20
GB2199033A (en) 1988-06-29
JPS63165381A (en) 1988-07-08
IE61325B1 (en) 1994-11-02
IL84521A (en) 1992-02-16
FR2610627A1 (en) 1988-08-12

Similar Documents

Publication Publication Date Title
GB8811645D0 (en) Novel 2-(5-fluoronicotinoyl)acetic acid derivative/salts thereof
FI88037B (en) PROCEDURE FOR FRAMSTATION OF PHARMACEUTICAL VAERDEFULLT CRYSTALLINE (4R, 5S, 6S, 8R, 2'S, 4'S) -3- / 4- (2-DIMETHYLAMINOCARBONYL) -PYRROLIDINYLTHIO / -4-METHYL-6- (1-HYDRO) - / 3.2.0 / hept-2-en-7-one-2-KARBOXYLSYRATRIHYDRAT
NO303687B1 (en) Analogous process for the preparation of the therapeutically active compound (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid
EP0197474A3 (en) Process for preparing optically active indoline-2-carboxylic acid
NO170330C (en) PROCEDURE FOR THE PREPARATION OF SIGNIFICANT OPTIC PURE MONOHYDRATE OF S - (-) - PROPYL-2 ', 6'-PIPECOLOXYLIDE HYDROCHLORIDE
IL66286A (en) Crystalline beta form of(3s-(3alpha(z),4beta))-3-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)-acetyl)amino)-4-methyl-2-oxo-1-azetidinesulfonic acid and method for preparation thereof
CS666688A2 (en) Method of 7 beta-/2-(r)-2-phenyl-2-aminoacetamide)-3-chloro-3-(1-carbadethiacephem)-4-carboxylic acid's crystalline monohydrate form preparation
FI875159A (en) Method for the preparation of therapeutically useful, (3S (Z)] - 2 - [[1- (2-amino-4-thiazolyl) -2- [2,2-dimethyl-4-oxo-1- (sulfooxy) - For the preparation of crystalline dierythromycin and dicoline salts of 3-azetidinyl / amino / -2-oxoethylidene / amino / oxy / acetic acid
SE8600355L (en) PROCEDURE FOR PREPARING 4,4-DIALKYL-2-AZETIDINONES
NO165393C (en) PROCEDURE FOR THE PREPARATION OF ARYLOXYPROPANOLAMINES AND SALTS OF THESE WITH DIPHENYLEDIC ACETIC ACID.
FI93216C (en) Analogous process for the preparation of therapeutically useful 1,3-dioxanoic acid derivatives
NO174887C (en) Analogous Process for Preparing Therapeutically Active Aryl-alkyl-Pyrrole-2-Carboxylic Acid Compounds
CS647985A2 (en) Method of (z)-2-(2-amino-4-thiazolyl)-2-(esterified-carboxyimino)acetic acid's heterothioester production
IT1196480B (en) PROCESS FOR THE PREPARATION OF NITROGEN HETEROCYCLIC COMPOUNDS
CS666588A2 (en) Method of 7 beta-/2-(r)-2-(p-hydroxyphenyl)-2-aminoacetamido/-3-chloro-3-(carbadethiacephem)-4-carboxylic acid's crystalline monohydrate form preparation
YU106787A (en) Process for obtaining monohydrate of optically pure s-(-)-1-propyl-2',6'pipecoloxylidid chlorinehydrate
KR870017202U (en) VTR's Reel Drive
KR870018947U (en) VTR's Tape Reel Drive
IT1170269B (en) PROCEDURE FOR PREPARING THE ACID DL 2- (6'-METOSSI-2'-NAFTIL) -PROPIONIC
NO174419C (en) Analogous Process for Preparing Therapeutically Active Heterocyclic Compounds

Legal Events

Date Code Title Description
BB Publication of examined application
BB Publication of examined application
MM Patent lapsed

Owner name: E.R. SQUIBB & SONS, INC.